Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 27, 2025Italian Journal of MedicineOpen Access

P127 | Dapagliflozin and acute pancreatitis: a case report

View Full Paper
Ask AI
Bookmark
Share

Discussion

Loading...

Member takes

Overview

Case report highlights dapagliflozin's potential role in acute pancreatitis, suggesting careful monitoring is needed.

Key Points

  • Acute pancreatitis was diagnosed in a 59-year-old male patient after starting dapagliflozin.
  • Initial lab tests showed significantly elevated lipase levels at 2378 U/L, supporting the diagnosis of pancreatitis.
  • Clinicians discontinued SGLT2 inhibitors and initiated conservative treatment with fluids and pain management.
  • This case emphasizes the need for awareness of SGLT2 inhibitors' association with pancreatitis and patient education.

Cite This Study

A 2025 study studied this question.

synapsesocial.com/papers/68af63efad7bf08b1eae4cd1https://doi.org/10.4081/itjm.2025.2323
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dapagliflozin-Induced Acute Pancreatitis: A Case Presentation and Review of the Literature2024 · 1 citations
  2. 2Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors and the Risk of Pancreatitis: A Case Report2024
  3. 3Empagliflozin-Associated Pancreatitis in the Setting of Hyperglycemic Hyperosmolar Syndrome2024
  4. 4Association Between <scp>SGLT2</scp> Inhibitors and <scp>DPP</scp> ‐4 Inhibitors Use and Risk of Acute Pancreatitis: Findings From Nationwide Case‐Based Analyses2026
  5. 5Probable Vildagliptin-Associated Acute Pancreatitis in a Patient With Well-Controlled Type 2 Diabetes Mellitus: A Case Report2026